Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination

© 2023. The Author(s)..

Several clinical trials have shown that the humoral response produced by anti-spike antibodies elicited by coronavirus disease 2019 (COVID-19) vaccines gradually declines. The kinetics, durability and influence of epidemiological and clinical factors on cellular immunity have not been fully elucidated. We analyzed cellular immune responses elicited by BNT162b2 mRNA vaccines in 321 health care workers using whole blood interferon-gamma (IFN-γ) release assays. IFN-γ, induced by CD4 + and CD8 + T cells stimulated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike epitopes (Ag2), levels were highest at 3 weeks after the second vaccination (6 W) and decreased by 37.4% at 3 months (4 M) and 60.0% at 6 months (7 M), the decline of which seemed slower than that of anti-spike antibody levels. Multiple regression analysis revealed that the levels of IFN-γ induced by Ag2 at 7 M were significantly correlated with age, dyslipidemia, focal adverse reactions to full vaccination, lymphocyte and monocyte counts in whole blood, Ag2 levels before the second vaccination, and Ag2 levels at 6 W. We clarified the dynamics and predictive factors for the long-lasting effects of cellular immune responses. The results emphasize the need for a booster vaccine from the perspective of SARS-CoV-2 vaccine-elicited cellular immunity.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Scientific reports - 13(2023), 1 vom: 13. Juni, Seite 9607

Sprache:

Englisch

Beteiligte Personen:

Ishii, Takashi [VerfasserIn]
Hamada, Kensuke [VerfasserIn]
Jubishi, Daisuke [VerfasserIn]
Hashimoto, Hideki [VerfasserIn]
Okamoto, Koh [VerfasserIn]
Hisasue, Naoko [VerfasserIn]
Sunohara, Mitsuhiro [VerfasserIn]
Saito, Minako [VerfasserIn]
Shinohara, Takayuki [VerfasserIn]
Yamashita, Marie [VerfasserIn]
Wakimoto, Yuji [VerfasserIn]
Otani, Amato [VerfasserIn]
Ikeda, Mahoko [VerfasserIn]
Harada, Sohei [VerfasserIn]
Okugawa, Shu [VerfasserIn]
Moriya, Kyoji [VerfasserIn]
Yanagimoto, Shintaro [VerfasserIn]

Links:

Volltext

Themen:

82115-62-6
BNT162 Vaccine
COVID-19 Vaccines
Interferon-gamma
Journal Article
RNA, Messenger
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 15.06.2023

Date Revised 28.06.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-023-36397-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35813417X